Aurobindo Gets USFDA Nod for Blood Pres­sure Drug

The Economic Times - - Companies: Pursuit Of Profit -

Aurobindo Pharma on Tues­day said it has re­ceived fi­nal ap­proval from the US health reg­u­la­tor to man­u­fac­ture and mar­ket generic ver­sion of blood pres­sure treat­ment drugs Am­lodip­ine and Val­sar­tan tablets. The ap­proval by USFDA is for mul­ti­ple strengths of 5mg/160mg, 5mg/320mg and 10mg/320 mg, the com­pany said in a BSE fil­ing

NEW DELHI

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.